L
Lisa A. Clough
Researcher at University of Kansas
Publications - 20
Citations - 443
Lisa A. Clough is an academic researcher from University of Kansas. The author has contributed to research in topics: Transplantation & Vancomycin. The author has an hindex of 10, co-authored 19 publications receiving 396 citations. Previous affiliations of Lisa A. Clough include Vanderbilt University.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial.
Drew J. Winston,F. Saliba,Emily A. Blumberg,M Abouljoud,Julia Garcia-Diaz,John A. Goss,Lisa A. Clough,Robin K. Avery,Ajit P. Limaye,Bo-Göran Ericzon,M. Navasa,Roberto Troisi,H Chen,Stephen Villano,Marc E. Uknis +14 more
TL;DR: At a dose of 100 mg twice daily, maribavir is safe but not adequate for prevention of CMV disease in liver transplant recipients at high risk forCMV disease.
Journal ArticleDOI
Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach.
N. Ganguly,Lisa A. Clough,L.K. DuBois,Joseph P. McGuirk,Sunil Abhyankar,Omar S. Aljitawi,N.K. O'Neal,Clint Divine,S Ganguly +8 more
TL;DR: Low‐dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation and a retrospective analysis of an algorithmic approach are analyzed.
Journal ArticleDOI
Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma
David W. Haas,Lisa A. Clough,Benjamin W. Johnson,Victoria L. Harris,Paul Spearman,Grant R. Wilkinson,Courtney V. Fletcher,Susan A. Fiscus,Stephen Raffanti,Ruth Donlon,Judy McKinsey,Janet Nicotera,Dennis E. Schmidt,Ronald E. Shoup,Robert E. Kates,Robert M. Lloyd,Brendan Larder +16 more
TL;DR: This study supports the utility of ultraintensive CSF sampling for studying HIV-1 pathogenesis and therapy in the CNS, and provides strong evidence that HIV- 1 RNA in CSF arises, at least in part, from a source other than plasma.
Journal ArticleDOI
Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection
David W. Haas,Julie A. Stone,Lisa A. Clough,Benjamin W. Johnson,Paul Spearman,Victoria L. Harris,Janet Nicotera,Regina H. Johnson,Stephen Raffanti,Ling Zhong,Paul Bergqwist,Steven Chamberlin,Vicki Hoagland,Ju William D +13 more
TL;DR: The cerebrospinal fluid‐to‐plasma AUC(0‐8) ratio suggests clearance mechanisms in addition to passive diffusion across the blood‐cerebro Spinal fluid barrier, perhaps by P‐glycoprotein–mediated efflux, may contribute to control of human immunodeficiency virus type 1 replication in this compartment.
Journal ArticleDOI
A Randomized Controlled Trial Examining the Efficacy of Motivational Counseling with Observed Therapy for Antiretroviral Therapy Adherence
Kathy Goggin,Mary M. Gerkovich,Karen B. Williams,Julie W. Banderas,Delwyn Catley,Jannette Berkley-Patton,Glenn J. Wagner,James F. Stanford,Sally Neville,Vinutha K. Kumar,David M. Bamberger,Lisa A. Clough +11 more
TL;DR: Findings of modest to null impact on adherence despite intensive interventions highlights the need for more effective interventions to maintain high adherence over time.